Brought to you by 
Nabi sells its biologics unit to Biotest for $185mm
25 Sep 2007
Executive Summary
Just three months after creating it, Nabi Biopharmaceuticals is selling its Nabi Biologics (plasma protein therapeutics and production) unit to Biotest AG (hematology and immunology therapeutics and diagnostics) for $185mm in cash.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Synthesis Technologies, Production Processes
-
Large Molecule
- Antibodies
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Intra-Biotech Deal
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Nabi sells its biologics unit to Biotest for $185mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice